| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/29/2000 | US6031110 Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides |
| 02/29/2000 | US6031103 Process for manufacturing 1-[3-cyclopentyl -2(R)-[1(R)-hydroxycarbamoyl)-2-(3, 4, 4-trimethyl -2, 5-D ioxo-1-imidazolidinyl) ethyl] propionyl] piperidine |
| 02/29/2000 | US6031102 Optically active pyridonecarboxylic acid derivatives |
| 02/29/2000 | US6031099 Piperidine derivates having anxiolytic effect |
| 02/29/2000 | US6031097 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands |
| 02/29/2000 | US6031094 Beta-lactam substrates and uses thereof |
| 02/29/2000 | US6030983 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 02/29/2000 | US6030982 Analogs of a 4-(2-((3,10-dibromo-8-chloro-4-(2-((3,10-dibromo-8-chloro-6,11 -dihydro-5h-benzo(5,6)-cyclohepta(1,2-b)pyrid-11-yl)-1-piperidinyl)-2 -oxothyl-betaoxo-1-piperidine; antitumor agents |
| 02/29/2000 | US6030972 2- or 5-aminomethyl,2- or 5-cyanopyrimidines as intermediates of anticoagulants in extracorporeal circulation (heart-lung machine, hemodialysis) |
| 02/29/2000 | US6030967 And/or like neurotrophic factor (for example, nerve growth factor (ngf), brain-derived neurotrophic factor, neurotrophin-3, and glial cell line-derived neurotrophic factor)-like activity; osteoporosis |
| 02/29/2000 | US6030966 Heterocyclic compound and their use |
| 02/29/2000 | US6030926 Pyrazole derivative and herbicidal composition |
| 02/29/2000 | CA2169179C 5-arylindole derivatives |
| 02/29/2000 | CA2117349C Benzopyrans and related ltb4 antagonists |
| 02/28/2000 | CA2280224A1 Ethers of polyalkyl or polyalkenyl n-hydroxyalkyl succinimdes and fuel compositions containing the same |
| 02/24/2000 | WO2000009498A1 Prodrugs of proton pump inhibitors |
| 02/24/2000 | WO2000009497A1 Improved omeprazole process and compositions thereof |
| 02/24/2000 | WO2000009496A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 02/24/2000 | WO2000009495A1 Isoquinoline derivatives with angiogenesis inhibiting activity |
| 02/24/2000 | WO2000009489A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 02/24/2000 | WO2000009488A1 Pyridazinone derivatives |
| 02/24/2000 | WO2000009487A1 Near infrared chemiluminescent acridinium compounds and uses thereof |
| 02/24/2000 | WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/24/2000 | WO2000009484A1 Pipecolic acid derivatives and their use for vision and memory disorders |
| 02/24/2000 | WO2000009480A1 Novel sulfonyl derivatives |
| 02/24/2000 | WO2000009479A2 Heterocyclic thioesters or ketones for vision and memory disorders |
| 02/24/2000 | WO2000009253A1 Reactor comprising a contact tube bundle |
| 02/24/2000 | WO2000009130A2 New pharmaceutical uses for nos inhibitors |
| 02/24/2000 | WO2000009126A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | WO2000009124A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009112A2 Heterocyclic esters or amides for vision and memory disorders |
| 02/24/2000 | WO2000009110A2 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | WO2000009107A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | WO2000009106A2 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 02/24/2000 | WO2000009105A2 Small molecule carbamates or ureas for vision and memory disorders |
| 02/24/2000 | WO2000009104A2 Use of sulfonamides for treating vision and memory disorders |
| 02/24/2000 | WO2000009098A2 Method for treating ocular neovascular diseases |
| 02/24/2000 | WO1999064050A8 Novel potassium channel drugs and their uses |
| 02/24/2000 | CA2340745A1 Azepinyland linear compounds and their use for vision and memory disorders |
| 02/24/2000 | CA2340702A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | CA2340668A1 Heterocyclic thioesters or ketones for vision and memory disorders |
| 02/24/2000 | CA2340200A1 New pharmaceutical uses for nos inhibitors |
| 02/24/2000 | CA2340167A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 02/24/2000 | CA2340100A1 Novel sulfonyl derivatives |
| 02/24/2000 | CA2338967A1 Improved omeprazole process and compositions thereof |
| 02/24/2000 | CA2336154A1 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 02/24/2000 | CA2336148A1 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2336088A1 Heterocyclic esters or amides for vision and memory disorders |
| 02/24/2000 | CA2336080A1 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2336060A1 Small molecule carbamates or ureas for vision and memory disorders |
| 02/24/2000 | CA2335813A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | CA2335810A1 Use of sulfonamides for treating vision and memory disorders |
| 02/23/2000 | EP0980358A1 Pharmacological agents |
| 02/23/2000 | EP0980357A1 Substituted tetrahydro isoquinolines as modulators of dopamine d3 receptors |
| 02/23/2000 | EP0980354A2 Vitamin d 3? analogs with bis c-20 side chains |
| 02/23/2000 | EP0980236A1 Colourant and method for producing temporary hair colours |
| 02/23/2000 | CN1245496A 3-pyridyl enantiomers and their use as analgesics |
| 02/23/2000 | CN1245492A Pesticidal 1-arylpyrazoles |
| 02/23/2000 | CN1245491A 5-cyclo indole compounds as 5-HT receptor ligands |
| 02/23/2000 | CN1245486A Ketobenzamides as calpain inhibitors |
| 02/23/2000 | CN1245169A Nitroketone compound, its preparing process and pharmaceutical composition containing same |
| 02/23/2000 | CN1245168A Amino quinoline derivatives |
| 02/23/2000 | CN1049659C Corticotropin releasing factor antagonists |
| 02/23/2000 | CN1049654C Piperazine derivatives and medicine composition containing same and use thereof |
| 02/23/2000 | CN1049651C Metalloproteinase inhibitors |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6028202 1,5-diarylpyrazoles |
| 02/22/2000 | US6028195 Piperazine derivatives and process for the preparation thereof |
| 02/22/2000 | US6028085 Indole derivatives as 5-HT receptor antagonist |
| 02/22/2000 | US6028082 For trating psychological disorders |
| 02/22/2000 | US6028081 Substituted quinolone derivatives and pharmaceuticals containing the same |
| 02/22/2000 | US6028080 For treating neurological disorders |
| 02/22/2000 | US6028079 Condensed-indan derivatives and pharmaceutically acceptable salts thereof |
| 02/22/2000 | US6028075 Administering pharmaceutically effective amount of a compound for treatment of tumor sensitive to the compound |
| 02/22/2000 | US6028073 For treating psychoses |
| 02/22/2000 | US6028072 For treating inflammation and inflammation related disorders |
| 02/22/2000 | US6028063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 02/22/2000 | CA2081356C Derivatives and analogues of 2-deoxy-2,3-didehydro-n- acetyl neuraminic acid and their use as antiviral agents |
| 02/22/2000 | CA2012498C Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions |
| 02/17/2000 | WO2000008202A2 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | WO2000008015A2 Fsh mimetics for the treatment of infertility |
| 02/17/2000 | WO2000008014A1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 02/17/2000 | WO2000008013A2 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 02/17/2000 | WO2000007999A1 Triazolone derivatives, use thereof, and intermediate therefor |
| 02/17/2000 | WO2000007997A1 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS |
| 02/17/2000 | WO2000007996A2 Pyrazoles as estrogen receptor modulators |
| 02/17/2000 | WO2000007995A1 SUCCINOYLAMINO LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 02/17/2000 | WO2000007993A1 Substituted isoquinoleines and their use as anticonvulsivants |
| 02/17/2000 | WO2000007991A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 02/17/2000 | WO2000007987A1 Crystalline forms of osanetant |
| 02/17/2000 | WO2000007980A1 Amide derivatives which are useful as cytokine inhibitors |
| 02/17/2000 | WO2000007593A1 Remedies or preventives for intractable epilepsy |
| 02/17/2000 | WO2000007542A2 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p |
| 02/17/2000 | WO1999044596A3 Glycine transport inhibitors |
| 02/17/2000 | DE19836792A1 Tube bundle reactor, for oxidation reactions, has partitioned headers allowing heat exchange medium supply to the lower header to be combined with co-current passage within the reactor |
| 02/17/2000 | DE19836697A1 New substituted 4-amino-2-aryl-pyrimidines, are soluble guanylate cyclase activators useful e.g. for treating atherosclerosis, hypertension, angina pectoris, thrombosis, asthma or diabetes |
| 02/17/2000 | DE19836044A1 New 2-(hetero)aryl-alkanoic acid derivatives, useful as mixed endothelin receptor antagonists, e.g. for treating cardiac insufficiency, restenosis, hypertension or prostate cancer |
| 02/17/2000 | DE19834325A1 New benzo-condensed heterocyclic compounds useful in treatment of thrombosis and prevention of vascular occlusion |
| 02/17/2000 | CA2383623A1 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | CA2339363A1 Remedies or preventives for intractable epilepsy |